Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

Bio€quity Europe 2012

16-May-2012
Finance | Pharmaceutical

15 - 16 May 2012
Conference
Frankfurt, Germany

15 - 16 May 2012
Conference
Frankfurt, Germany

BioEquity 2012 is the leading venue for public and private biotech investors throughout Europe. Together, BioCentury Publications, EBD Group, and BIO will be producing the 13th edition of this annual international conference

Organiser: EBD Group

Companies

  • TiGenix
  • EBD Group

Related Content

Takeda announces its intention to acquire TiGenix
Takeda announces its intention to acquire TiGenix
TiGenix expands manufacturing facility
TiGenix expands manufacturing facility
TiGenix partners with US and EU patient advocacy groups focused on Crohn's disease and ulcerative colitis
TiGenix partners with US and EU patient advocacy groups focused on Crohn's disease and ulcerative colitis
Takeda makes €10 million equity investment in TiGenix
Takeda makes €10 million equity investment in TiGenix
TiGenix to acquire Coretherapix for €6.7m
TiGenix to acquire Coretherapix for €6.7m
Lonza to manufacture Crohn's Disease treatment for TiGenix clinical trial in US
Lonza to manufacture Crohn's Disease treatment for TiGenix clinical trial in US
TiGenix to sell Dutch manufacturing facility to PharmaCell
TiGenix to sell Dutch manufacturing facility to PharmaCell
ChinaBio Partnering Forum 2013
ChinaBio Partnering Forum 2013
BIO-Europe 2013
BIO-Europe 2013
VFB Biotech Congress
VFB Biotech Congress
BIO International Convention
BIO International Convention
Knowledge for Growth
Knowledge for Growth
BIO-Europe Spring
BIO-Europe Spring
BIO-Europe 2010
BIO-Europe 2010
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company